Good MorningEquities rebounded on Wednesday despite another round of bearish news that included the PPI data and earnings from JPMorgan Chase. The PPI data shows producer prices accelerating more than expected to the fastest pace on record. This data is sure to lead to another increase in the CPI data next month or later in the year which brings us to the JPMorgan Chase report. The company says it is bracing for increased economic risks and we think it is a wise decision.
The impacts of Russia's invasion of Ukraine are only beginning to show up in the data and results and those impacts are not good. Rising fuel costs and disruptions to trade are only the tip of the iceberg and threaten to throw the global economy into a recession. The next hurdle for the market will come today with an earnings report from at least half a dozen of the world's largest financial institutions. If they report more of what JPMorgan Chase reported the market sell-off could resume with increased vigor. Featured: Millionaire Trader Drops Bombshell… “The Only Trade You Will Ever Need” (Legacy Research) 
|
Markets | | |
These stocks combine solid fundamentals with a stock price near its 52-week low
Some of you with children may participate in an Easter Egg hunt this weekend. If that’s the case for you, I hope your kids come home with lots of little treasures.
That got me thinking. With t... Read the Full Story |
|
|
Markets | | | Asian shares fell in muted trading as markets were closed for Good Friday and other holidays.
Benchmarks declined in Tokyo, Seoul and Shanghai. Sydney, Manila, Bangkok and Hong Kong were among markets observing holidays on Friday. U.S. and European markets also were closed.
... Read the Full Story |
|
Tech | | |
These 3 S&P Stocks Could Be Bargains
One of the most common pieces of advice when it comes to investing is to “buy low and sell high”. While this definitely sounds good on paper, finding the right opportunities in the market at the right time is easier said than done. That’s... Read the Full Story |
|
From Our PartnersYou see, although the Russian oil supply crisis is creating havoc around the world… there are two stocks worth investment consideration. One is a blue chip, multinational energy company that recently crushed its revenue and earnings estimates. Hedge funds are pouring money into it. The other stock recently almost doubled in 26 days.
(**By clicking link you are subscribing to The Wealthiest Investor News’ Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.) | | Discover the names of these two stocks now |
|
Markets | | |
Solar tracking systems provider Array Technologies (NASDAQ: ARRY) stock has fallen below its pandemic lows despite improving business. The Company manufactures and supplies single-axis solar tracking systems that enable the optimal positioning of a solar array to increase clean and renewable energ... Read the Full Story |
|
Markets | | |
Robotic process automation (RPA) platform provider UiPath (NASDAQ: PATH) stock has been getting crushed to new lows ever since hitting highs of $90 nearly a year ago. The Company is a leader in RPA, which enables companies to better automate their repetitive processes. It’s both software rob... Read the Full Story |
|
From Our PartnersGold IRAs are one of the many low-risk ways you can invest as a senior, offering an opportunity to both protect and grow your earnings. We will show you how you can roll over your IRA or 401(k) into precious metals. Tax free & penalty-free into an IRA holding using a loophole the IRS doesn't want you to know! | | Get your free gold investing guide here! |
|
Politics | | | President Joe Biden said Friday he plans to nominate Michael Barr, the dean of the University of Michigan's public policy school, to be the Federal Reserve's vice chairman of supervision.
The selection of Barr comes after Biden’s first choice for the Fed post, Sarah Bloom Raskin, with... Read the Full Story |
|
Politics | | | MOSCOW — Russia’s Defense Ministry on Friday promised to ramp up “the scale of missile attacks” on Kyiv in response to Ukraine’s “diversions on the Russian territory.”
The statement comes a day after Russian authorities accused Ukrainian forces of launching airstrikes on residential ... Read the Full Story |
|
Markets | | | The first of four men accused in a failed plan to build a biotechnology plant in Vermont using tens of millions of dollars in foreign investors’ money raised through a special visa program has been sentenced to 18 months in federal prison Read the Full Story |
|
Tech | | | A lawyer for California's civil rights agency resigned over what she alleges were undue attempts by Gov. Gavin Newsom and his office to interfere in a state lawsuit against video game giant Activision Blizzard Read the Full Story |
|
Markets | | | Lululemon Athletica (NASDAQ: LULU) impressed the market when it reported fiscal Q4 earnings at the end of March. The company beat on the bottom line and raised its guidance as demand and pricing combined to boost the earnings results. Read the Full Story |
|
Friday's Early Bird Stock Of The Day Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts. | | View Today's Stock Pick |
|
